Cancer Consortium Traces Signature For Lung Cancer Recurrence | GenomeWeb

Early-stage lung cancer patients are usually treated surgically and sent home, but 25 percent to 30 percent of those people will have their cancer recur. Researchers from cancer institutes in the United States and Canada are paving the way to develop gene expression panels to predict which lung cancer patients will relapse. "If you know who these high-risk patients are, then you would potentially be able to offer them additional therapy," says David Beer, a professor of surgery and radiation oncology at the University of Michigan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.